Clinical Trials Browser

Breast Neoplasms, Endocrine Gland Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Skin Neoplasms, Soft Tissue Neoplasms, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT07606430 2026-05-26

BRIDGE-8

Phase NA Not yet recruiting

116 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07607119 2026-05-26

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

Phase NA Recruiting

53 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02350530 2026-05-22

FORBES

Phase 2 Completed

138 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02572141 2026-05-22

OPTICAL

Phase 3 Active not recruiting

738 enrolled

Gastrointestinal

Colonic Neoplasms

NCT03068403 2026-05-22

RECT

Phase NA Completed

2 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03095781 2026-05-22

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Phase 1 Completed

47 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms

NCT03548961 2026-05-22

Organ Preservation in Early Rectal Cancer Patients

Phase 2 Active not recruiting

19 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03896646 2026-05-22

Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

Phase NA Active not recruiting

42 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04007770 2026-05-22

Acupuncture Pilot Study for Cancer-related Cognitive Function

Phase 2 Active not recruiting

48 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04017650 2026-05-22

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Phase 1/2 Active not recruiting

38 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Disease Progression

NCT04196465 2026-05-22

NeoChance

Phase 2 Active not recruiting

48 enrolled

Gastrointestinal

Liver Neoplasms

NCT04230187 2026-05-22

TRIBE-C

Phase 3 Active not recruiting

528 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04452357 2026-05-22

Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

Phase NA Active not recruiting

12 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04484909 2026-05-22

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Phase 1 Active not recruiting

24 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

Bridge CRC

ASPIRES

Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer

HER Image

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery

HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

REVIVE

NEST3

Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer

PROTECT-Lynch

TRACK

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

RACCOON

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

CHORDA-II-p

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Ablatio

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

SCREEN-HPV

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

COFRUQ

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

PACHA-02

X-CLOSURE

SC-Stoma

Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital

BRIDGE-8

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

FORBES

OPTICAL

RECT

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Organ Preservation in Early Rectal Cancer Patients

Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

Acupuncture Pilot Study for Cancer-related Cognitive Function

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

NeoChance

TRIBE-C

Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer